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INTRODUCTION
Postponed pregnancy is a challenge for physicians
dealing with infertility, because the factors that influ-
ence the success treatment of infertility is the age.
Physicians are usually faced with the fact that ovarian
reserve has decreased with the increasing age of pa-
tients. Although the relationship between age and
ovarian reserve varies considerably, several cases
showed that younger women had lower ovarian re-
serve than older women, to the extent that objective
data were required to determine ovarian reserve.1,2
One of the options in the management of infertili-
ty is in vitro fertilization (IVF). The relatively high
cost of IVF has usually become a concern for infertile
couples to participate in the IVF program. Thus, it is
necessary to have the examination of ovarian reserve
therefore the success of IVF could be predicted.2
Several indicators of ovarian reserve include basal
follicle stimulating hormone (FSH), basal estradiol,
and basal antral follicle (BAF) count.1 Of these in-
dicators, the number of BAF was the most sensitive.3
However, the results of the examinations were largely
dependent on the type of ultrasonography (USG) used
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Objective: To evaluate the clinical value of Anti Mullerian Hor-
mone serum (AMH) level as one of ovarian response indicator in
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Method: This cohort-prospective study was conducted in Dr.
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Abstrak
Tujuan: Untuk mengevaluasi nilai klinis pengukuran kadar Anti
Mullerian Hormone (AMH) sebagai parameter respons ovarium pa-
da program Fertilisasi In Vitro (FIV).
Metode: Penelitian dilakukan di RS Dr. Cipto Mangunkusumo
dengan rancangan penelitian prospektif kohort. Pasien infertilitas
yang menjalani hiperstimulasi ovarium terkendali pada program
FIV dilakukan pengukuran kadar FSH, estradiol, AMH dan peng-
hitungan folikel antral basal (FAB). Pasien tersebut dikategorikan
menjadi dua kelompok, yaitu perespons baik dan perespons buruk.
Kelompok perespons baik memiliki oosit matur ≥ 3 buah saat di-
lakukan petik oosit. Sedangkan kelompok perespons buruk memiliki
oosit matur < 3 buah. Analisis statistik menggunakan uji T tidak
berpasangan dan Receiver Operator Characteristic (ROC) untuk
melihat apakah AMH lebih superior dibandingkan faktor penduga
antara yang lain.
Hasil dan Pembahasan: Dari 92 siklus, 15 siklus (16,3%) dika-
tegorikan perespons buruk dan 77 perespons baik. Rerata kadar
AMH pada perespons baik adalah 3,75 ± 2,77 μg/ml dan 1,04 ± 1,39
μg/ml pada perespons buruk (p < 0,0001). Berdasarkan ROCAUC,
AMH merupakan faktor penduga respons ovarium yang baik (AUC
0,846) dibandingkan faktor penduga yang lain seperti usia, FSH,
estradiol, dan FAB. Nilai titik potong AMH yang didapatkan adalah
1,40 μg/ml dengan nilai sensitivitas sebesar 81% dan spesifisitas se-
besar 87%.
Kesimpulan: AMH merupakan faktor penduga respons ovarium
yang lebih baik dibandingkan usia, FSH, Estradiol, dan FAB.
[Maj Obstet Ginekol Indones 2010; 34-3: 114-8]
Kata kunci: hormon anti-Mullerian, cadangan ovarium, res-
pons ovarium
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and the skills of its operator, to the extent that a more
accurate and easy-to-use examination was needed to
determine the exact ovarian reserve. Until recently,
doubts have been cast on the accuracy of the value
of basal FSH in predicting ovarian reserve because a
number of patients with normal FSH values had been
found to have inadequate ovarian reserve.
AMH is a dimeric glycoprotein structure and be-
longs to the group of transforming growth factor β
(TGF β). AMH plays a vital role in the development
and maturation of follicles. AMH is produced by ova-
rian granulosa cells since pregnancy age of 36 weeks
and impedes the primordial follicle taking during the
early taking phase, such that it may prevent depletion
of primordial follicles. For this reason, AMH belongs
to one of the regulators of folliculogenesis which in-
directly describes the number of antral follicles and
may provide an indication of ovarian reserve. In addi-
tion to being used to identify ovarian reserve, AMH
is also beneficial in providing ovarian response. By
identifying the level of AMH, the number of mature
oocytes obtained could be predicted and the appro-
priate total amount of gonadotropin dose could be
used in the controlled ovarian hyperstimulation in the
IVF program.4,5
This study aimed to identify the values of AMH,
compared to FSH, estradiol and BAF count as the
parameters of ovarian reserve and response in IVF.
In addition, this study aimed to identify the correla-
tion between AMH level and the total dose of gona-
dotropin used in the controlled ovarian hyperstimula-
tion in the IVF program.
METHOD
Design of the study was prospective cohort. Eighty
four patients who undergoes 92 cycles of IVF at Dr.
Cipto Mangunkusumo General Hospital were the sub-
jects of this study. The inclusion criteria were both
ovaries could be visualized at USG examination, the
number of BAF of the patient could be counted, no
history of ovarian surgery, and no history of chemo-
therapy and radiation.
FHS and estradiol levels were examined on day 2
or day 3 of menstruation cycle, in addition to AMH
level measurements on any day throughout the mens-
trual cycle by using AMH DSL-10-14400 kit. Trans-
vaginal ultrasonography was used to calculate the
number of antral follicles on day 2 or day 3 of mens-
truation cycle using SA Medison 8000 ultrasound.
Ovarian stimulation used both the long-term and
short-term protocols. With the long-term protocol, an
injection of GnRH agonist was administered at a dose
of 500 μg since the intermediate luteal phase for 10
- 14 days. Furthermore, gonadotropin was used at a
dose adjusted to the patient’s age, the monitoring of
estradiol level, and the follicle development at USG
examination. Gonadotropin doses used were 150, 225
or 300 IU since the second day of menstruation cycle.
GnRH agonist dose was lowered to 250 μg/day. After
the first five days of gonadotropin injection, we car-
ried out monitoring follicle growth with ultrasono-
graphy and examined blood estradiol level every three
days. When at least three follicles with diameter of
18 - 20 mm were found, an injection of human chorionic
gonadotropin (hCG) was administered, and oocyte
pick-up was performed within 36 hours.
In the short-term protocol, we used GnRH antago-
nist in which cetrorelix® was administered intrave-
nously with an injection of 0.25 mg every day since
day 6 of stimulation or when the largest follicle with
a diameter of 14 mm was found. The benefits of using
GnRH antagonist include shorter time and smaller
number of GnRH analogs employed, and the ability
to reduce risks of excessive ovarian stimulation.
In this study, patients were divided into two groups
on the basis of the number of oocytes retrieved during
oocyte pick-up after the controlled ovarian hypersti-
mulation. Group with ≥ 3 oocytes is classified into
the good responders.
Statistical analysis made use of SPSS 16. The sta-
tistical test was carried out using unpaired T test,
while Receiver Operator Characteristic (ROC) was
used to observe the sensitivity and specificity of each
variable.
RESULTS
Eighty four women participated in 92 IVF cycles were
included in the current study. These women were sub-
jected to the examination of basal FSH, basal estra-
diol, AMH levels, and the calculation of BAF. They
were divided into two groups based on the ovarian
response to the stimulation. If three or more mature
oocytes were found, they would be grouped into the
cycle of good responders. On the other hand, if two
or less mature oocytes were found, they would be
grouped into the cycle of poor responders. Fifteen out
of 92 cycles (16.3%) were classified as the cycles of
poor responders, and 77 cycles (83.7%) were consid-
ered the cycles of good responders.
Data of patients’ characteristics were shown in Ta-
ble 1. Of 92 cycles, 18 cycles (20%) were found to
experience clinical pregnancy. And 86 cycles (93.5%)
constituted primary infertility. Based on the causes of
infertility, the most common factors were male factor
(44/92; 48%), tubal factor (16/92; 17.4%), endo-
metriosis (8/92; 8%), combined female and male fac-
tors (13/92; 14.3%). The protocols used were the
long-term protocol (70/92; 76.2%), short-term proto-
col (14/92; 15%), and the rest was minimal stimula-
tion (8/92; 8.8%). Older patients with diminished
ovarian reserve were stimulated using the protocol of
minimal stimulation.
Table 1 shows the factors associated with ovarian
reserve, i.e. age, FSH level, the number of BAF, and
AMH level. It shows that younger patients had better
ovarian reserve and response. In addition, lower FSH
level correlates with better ovarian response. This was
due to the fact that if there was some poor ovarian
reserve found in patients with diminished ovarian re-
serve, the basal FSH level would be higher. It was
obvious that patients with better ovarian response and
belong to the group of good responders were those
with younger ages, lower FSH level, a greater number
of BAF, and higher AMH level.
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Diagram of ROCAUC of the four variables that in-
dicate ovarian reserve can be seen in Figure 1. Cut-off
point for age is 35 years in which age less than 35.5
years had a good prediction of ovarian response, with
sensitivity of 64% and specificity of 57% (AUC =
0.707; p = 0.012; 95% CI 0.585 - 0.829). FSH level
had a cut-off point of 7.25 IU/l in which FSH level
lower than 7.25 IU/l had a good prediction of ovarian
response, with sensitivity of 73% and spe-cificity of
74% (AUC = 0.765; p = 0.002; 95% CI 0.619 -
0.910). The number of BAF had a cut-off point of
7.5 in which the number of BAF greater than seven
follicles had a good prediction of ovarian res-ponse,
with sensitivity of 73% and specificity of 82% (AUC
= 0.843; p < 0.0001; 95% CI 0.732 - 0.959). AMH
level had a cut-off point of 1.40 μg/ml in which AMH
level higher than 1.40 μg/ml had a good predic- tion
of ovarian response, with sensitivity of 81% and
specificity of 87% (AUC = 0.846; p < 0.0001; 95% CI
0.735 - 0.968). These findings are shown in Figure 1.
Table 2. ROCAUC Age, FSH level, BAF, and AMH level
in predicting ovarian response.
Predictive factor ROCAUC Significance
Age 0.707 0.012
FSH 0.765 0.001
BAF 0.843 < 0.0001 
AMH 0.846 < 0.0001 
Multivariate analysis of factors affecting the ovar-
ian response showed that the most dominant factor
was AMH, followed by the number of BAF. On the
other hand, age and FSH level were not included in
the analysis of linear regression since they did not
meet the requirements (p > 0.25). Hence, we compose
a linear regression formula for ovarian reserve and
response, where mature oocyte counts = 1.544 +
0.686 x AMH level + 0.356 x BAF counts. If only
one variable was present, i.e. AMH level, the equation
of linear regression would be the number of mature
oocytes = 3.690 + 0.910 x AMH level. If it was to
be based on the number of BAF, the equation of linear
regression would be the number of mature oocytes
1.745 + 0.607 x the number of BAF. This could be
seen in Figure 2. Therefore, it can be concluded that
AMH level was the most dominant factor in determi-
ning the ovarian reserve and response, which was fol-
lowed by the number of BAF.
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Figure 1. Receiver Operator Characteristic (ROC).
Table 1. Characteristic data of good and poor responders groups.
Good respond (n = 77) Poor respond (n = 15) p value
Age (year) 34.45 ±  4.29 38.33 ±  4.53 0.001 
IMT (kg/m2) 23.14 ±  3.18 23.68 ±  3.89 0.639 
FSH level (IU/l)  7.06 ±  3.40 13.64 ±  8.43 0.010 
Estradiol level (pmol/l) 50.7  ± 38.5 51.1  ± 39.63 0.976 
AMH level (g/ml)  3.75 ±  2.77  1.05 ±  1.39 0.0001
BAF (number)  8.88 ±  3.4  4.47 ±  2.88 0.0001
Mature oocyte (number)  7.28 ±  3.33  1.55 ±  0.52 0.0001
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Figure 2 shows the equation of linear regression,
i.e. the number of mature oocyte = 3.690 + 0.625 x
AMH level (above) and the number of mature oocytes
= 1.745 + 0.549 x the number of BAF (below). If
both variables were combined, they would result in
the following equation of linear regression: the num-
ber of mature oocytes = 1.544 + 0.468 x AMH level
+ 0.322 x the number of BAF.
In addition to serve as a useful predictive factor of
the number of mature oocytes, AMH level had an in-
verse correlation to the total dose of gonadotropin
used in IVF (p = 0.047; r = -0.232). This could only
be applied in the long-term protocol or short-term pro-
tocol, not in the minimal stimulation which was usu-
ally applied in patients with diminished ovarian re-
serve. In the current study, if the natural cycle was
excluded then we would have an inverse correlation
between AMH level and the total dose of gonadotro-
pin. If AMH level in the early period of IVF was found
to be high, the dose of gonadotropin used should be
lower than if AMH level in the early period of IVF was
low, in order to achieve the similar ovarian response.
These findings could be seen in Figure 3.
DISCUSSION
In this study, the cycles with good ovarian reserve
and response were found in patients with younger age.
The correlation between ovarian response and age was
indubitably clear. All indicators of ovarian reserve
correlated with age. Although in several different
cases a decrease in ovarian reserve was found, in
women with the same ages.1,6,7 The causes of this
condition include the use of chemotherapy, radiation,
history of ovarian surgery, and others.8,10 On the
other hand, body mass index (BMI) did not show any
significant difference between both groups (p = 0.639)
in this study.
The AUC value of AMH level (AUC 0.846) was
the highest in comparison with other factors, followed
by the number of BAF (AUC 0.843). This shows that
AMH level constituted the most superior parameter
in this study, a finding that was consistent with the
study conducted by Visser et al11 and Kwee et al.12
AMH level is the most novel and superior predictive
factor of ovarian reserve and response. AMH level
had several benefits compared with BAF count. The
results of BAF count were dependent on the type of
USG used and the skills of its operator, while with
AMH only venous serum was needed for its exami-
nations. Furthermore, AMH was not affected by men-
strual cycle, something different from FSH and estra-
diol levels which should be examined on day two or
day three of the menstrual cycle.
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Figure 3. Correlation between total doses of gonadotropin used
in IVF and AMH level.
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Figure 2. The equation of linear regression, i.e. the number of
mature oocyte = 3.690 + 0.625 x AMH level (A) and the number
of mature oocytes = 1.745 + 0.549 x the number of BAF (B).
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In addition, to identify ovarian reserve, AMH level
could also be employed to predict the total dose of
gonadotropin used in controlled ovarian hyperstimu-
lation in IVF program. This was due to the fact that
there was a correlation between AMH level and the
total dose of gonadotropin used in this study. This
finding was consistent with the study performed by
Kwee et al.12
CONCLUSION
Anti Mullerian Hormone (AMH) has the benefits in
predicting ovarian response toward ovarian stimula-
tion in the IVF program. Overall, AMH was more
superior than other predictive factors. AMH level also
has a correlation with the total dose of gonadotropin
used in controlled ovarian hyperstimulation in IVF.
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